These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 28254115)
21. Lacosamide serum concentrations in adult patients with epilepsy: the influence of gender, age, dose, and concomitant antiepileptic drugs. Markoula S; Teotonio R; Ratnaraj N; Duncan JS; Sander JW; Patsalos PN Ther Drug Monit; 2014 Aug; 36(4):494-8. PubMed ID: 24562047 [TBL] [Abstract][Full Text] [Related]
22. Monitoring Protein-Unbound Valproic Acid Serum Concentrations in Clinical Practice. Wallenburg E; Klok B; de Jong K; de Maat M; van Erp N; Stalpers-Konijnenburg S; Essink G; van Luin M Ther Drug Monit; 2017 Jun; 39(3):269-272. PubMed ID: 28437285 [TBL] [Abstract][Full Text] [Related]
23. Lack of pharmacokinetic interaction between valproic acid and a traditional Chinese medicine, Paeoniae Radix, in healthy volunteers. Chen LC; Chou MH; Lin MF; Yang LL J Clin Pharm Ther; 2000 Dec; 25(6):453-9. PubMed ID: 11123499 [TBL] [Abstract][Full Text] [Related]
24. Reduction in blood free carnitine levels in association with changes in sodium valproate (VPA) disposition in epileptic patients treated with VPA and other anti-epileptic drugs. Hiraoka A; Arato T; Tominaga I Biol Pharm Bull; 1997 Jan; 20(1):91-3. PubMed ID: 9013816 [TBL] [Abstract][Full Text] [Related]
25. Valproic acid plasma concentration decreases in a dose-independent manner following administration of meropenem: a retrospective study. Haroutiunian S; Ratz Y; Rabinovich B; Adam M; Hoffman A J Clin Pharmacol; 2009 Nov; 49(11):1363-9. PubMed ID: 19773524 [TBL] [Abstract][Full Text] [Related]
26. Valproic acid-carbapenem interaction: report of six cases and a review of the literature. Tobin JK; Golightly LK; Kick SD; Jones MA Drug Metabol Drug Interact; 2009; 24(2-4):153-82. PubMed ID: 20408498 [TBL] [Abstract][Full Text] [Related]
27. Effects of amoxicillin/clavulanic acid on the pharmacokinetics of valproic acid. Lee SY; Huh W; Jung JA; Yoo HM; Ko JW; Kim JR Drug Des Devel Ther; 2015; 9():4559-63. PubMed ID: 26309401 [TBL] [Abstract][Full Text] [Related]
28. Factors Influencing Sodium Valproate Serum Concentrations in Patients with Epilepsy Based on Logistic Regression Analysis. Lan X; Mo K; Nong L; He Y; Sun Y Med Sci Monit; 2021 Nov; 27():e934275. PubMed ID: 34776507 [TBL] [Abstract][Full Text] [Related]
29. Empirical approach for improved estimation of unbound serum concentrations of valproic acid in epileptic infants by considering their physical development. Ueshima S; Aiba T; Sato T; Matsunaga H; Kurosaki Y; Ohtsuka Y; Sendo T Biol Pharm Bull; 2011; 34(1):108-13. PubMed ID: 21212527 [TBL] [Abstract][Full Text] [Related]
30. [Pharmacokinetic interaction between valproic acid and meropenem]. Sala Piñol F; Padullés Zamora N; Hidalgo Albert E; Clemente Bautista S; Cabañas Poy MJ; Oliveras Arenas M; Balcells Ramírez J An Pediatr (Barc); 2006 Jan; 64(1):93-5. PubMed ID: 16539924 [TBL] [Abstract][Full Text] [Related]
31. Influence of uridine diphosphate glucuronosyltransferase 2B7 -161C>T polymorphism on the concentration of valproic acid in pediatric epilepsy patients. Inoue K; Suzuki E; Yazawa R; Yamamoto Y; Takahashi T; Takahashi Y; Imai K; Koyama S; Inoue Y; Tsuji D; Hayashi H; Itoh K Ther Drug Monit; 2014 Jun; 36(3):406-9. PubMed ID: 24365988 [TBL] [Abstract][Full Text] [Related]
32. Apparent clearance of valproic acid in elderly epileptic patients: estimation of the confounding effect of albumin concentration. Lampon N; Tutor JC Ups J Med Sci; 2012 Mar; 117(1):41-6. PubMed ID: 22206465 [TBL] [Abstract][Full Text] [Related]
33. Characterization of non-linear relationship between total and unbound serum concentrations of valproic acid in epileptic children. Ueshima S; Aiba T; Makita T; Nishihara S; Kitamura Y; Kurosaki Y; Kawasaki H; Sendo T; Ohtsuka Y; Gomita Y J Clin Pharm Ther; 2008 Feb; 33(1):31-8. PubMed ID: 18211614 [TBL] [Abstract][Full Text] [Related]
34. [The clinical relevance of serial determinations of plasma concentrations of carbamazepine and sodium valproate]. Hernández-Fustes OJ; Marcourakis T; de Bittencourt PR Rev Neurol; 1999 Jun 1-15; 28(11):1043-7. PubMed ID: 10390769 [TBL] [Abstract][Full Text] [Related]
35. Increased erythrocyte distribution of valproic acid in pharmacokinetic interaction with carbapenem antibiotics in rat and human. Omoda K; Murakami T; Yumoto R; Nagai J; Maeda Y; Kiribayashi Y; Takano M J Pharm Sci; 2005 Aug; 94(8):1685-93. PubMed ID: 15986463 [TBL] [Abstract][Full Text] [Related]
36. Effect of concomitant administration of meropenem and valproic acid in an elderly Chinese patient. Gu J; Huang Y Am J Geriatr Pharmacother; 2009 Feb; 7(1):26-33. PubMed ID: 19281938 [TBL] [Abstract][Full Text] [Related]
37. Potential relationships between transaminase abnormality and valproic acid clearance or serum carnitine concentrations in Japanese epileptic patients. Goto S; Seo T; Hagiwara T; Ueda K; Yamauchi T; Nagata S; Ando Y; Ishitsu T; Nakagawa K J Pharm Pharmacol; 2008 Feb; 60(2):267-72. PubMed ID: 18237476 [TBL] [Abstract][Full Text] [Related]
38. Population pharmacokinetics of valproic acid in epileptic children: Effects of clinical and genetic factors. Xu S; Chen Y; Zhao M; Guo Y; Wang Z; Zhao L Eur J Pharm Sci; 2018 Sep; 122():170-178. PubMed ID: 29981400 [TBL] [Abstract][Full Text] [Related]
39. Effect of delayed and/or missed enteric-coated divalproex doses on valproic acid concentrations: simulation and dose replacement recommendations for the clinician. Dutta S; Reed RC J Clin Pharm Ther; 2006 Aug; 31(4):321-9. PubMed ID: 16882100 [TBL] [Abstract][Full Text] [Related]
40. Epileptic seizures caused by low valproic acid levels from an interaction with meropenem. Fudio S; Carcas A; Piñana E; Ortega R J Clin Pharm Ther; 2006 Aug; 31(4):393-6. PubMed ID: 16882111 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]